# Cisatracurium Besylate

NDC: 55150-286
Generic name: Cisatracurium Besylate
Labeler / Manufacturer: Eugia US LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20200508

FDA application: ANDA209144

## Active ingredients

- CISATRACURIUM BESYLATE: 20 mg/10mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55150-286"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55150-286
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2cb05c7e-6228-4e2d-a270-7659e3db3fa7